EU approves Norvatis’ Cosentyx for childhood arthritis - Drug Informics

Post Top Ad

Monday, 27 June 2022

EU approves Norvatis’ Cosentyx for childhood arthritis

Cosentyx receives expanded approvals in EU for use in childhood arthritic conditions

from PharmaTimes: News RSS https://ift.tt/iTJSdtM

No comments:

Post a Comment

Post Top Ad